EGR1 and Parkinson disease: Among those, the three DE transcripts which exhibited the most significant decrease in the SN of PD patients in our dataset were syndecan‐4 (SDC4), calcium/calmodulin‐dependent protein kinase IV (CAMK4), and early growth response 1 (EGR1).